title: The failure of immune checkpoint blockade in multiple myeloma with PD-1 inhibitors in a phase 1 study.
authors.affiliation: Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors.forename: H
authors.initials: H
authors.lastname: Suen
authors.affiliation: Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Brown
authors.affiliation: Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Yang
authors.affiliation: Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors.forename: P J
authors.initials: PJ
authors.lastname: Ho
authors.affiliation: Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors.forename: J
authors.initials: J
authors.lastname: Gibson
authors.affiliation: Institute of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Joshua
mesh_terms: D060890:B7-H1 Antigen / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D009101:Multiple Myeloma / Q000276:immunology*; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D060890:B7-H1 Antigen; D061026:Programmed Cell Death 1 Receptor